Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 1998;21:597 603. 863. Gori T, Di Stolfo G, Sicuro S, et al. Nitroglycerin protects the endo- thelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol. 2007;64:145 50. 864. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci. 2002;962:18 41. 865. Jneid H, Chandra M, Alshaher M, et al. Delayed preconditioning- mimetic actions of nitroglycerin in patients undergoing exercise tol- erance tests. Circulation. 2005;111:2565 71. 866. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med. 1998;338:520 31. 867. Bottcher M, Madsen MM, Randsbaek F, et al. Effect of oral nitroglyc- erin and cold stress on myocardial perfusion in areas subtended by stenosed and nonstenosed coronary arteries. Am J Cardiol. 2002;89: 1019 24. 868. Munzel T, Mulsch A, Kleschyov A. Mechanisms underlying nitroglyc- erin-induced superoxide production in platelets: some insight, more questions. Circulation. 2002;106:170 2. 869. Lacoste LL, Theroux P, Lidon RM, et al. Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris. Am J Cardiol. 1994;73:1058 62. 870. Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618 28. 871. Gori T, Parker JD. The puzzle of nitrate tolerance: pieces smaller than we thought? Circulation. 2002;106:2404 8. 872. Azevedo ER, Schofield AM, Kelly S, et al. Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine. J Am Coll Cardiol. 2001;37:505 9. 873. Heitzer T, Just H, Brockhoff C, et al. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril. J Am Coll Cardiol. 1998;31:83 8. 874. Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049 57. 875. Gogia H, Mehra A, Parikh S, et al. Prevention of tolerance to hemo- dynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol. 1995;26: 1575 80. 876. DeMots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989;13: 786 95. 877. Chrysant SG, Glasser SP, Bittar N, et al. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol. 1993;72:1249 56. 878. Parker JO, Amies MH, Hawkinson RW, et al. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Circulation. 1995;91:1368 74. 879. Abrams J. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. Drugs. 1987;34:391 403. 880. Iafrate RP Jr, Yost RL, Curry SH, et al. Effect of dose and ointment application technique on nitroglycerin plasma concentrations. Pharma- cotherapy. 1983;3:118 24. 881. Moe G, Armstrong PW. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure. Am J Med. 1986; 81:765 70. 882. Silber S. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide mononitrate. Eur J Clin Pharmacol. 1990;38 Suppl 1:S35 S51. 883. CV Therapeutics. Ranexa Package Insert. http://www.cvt.com/pdf/ RanexaPI.pdf. 2007. Available at: http://www.cvt.com/pdf/RanexaPI. pdf. Accessed July 15, 2008. 884. Chaitman BR, Skettino SL, Parker JO, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol. 2004;43:1375 82. 885. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. Effects of ranolazine on recurrent cardiovascular events in patients with non- STelevation acute coronary syndromes: the MERLIN-TIMI 36 ran- domized trial. JAMA. 2007;297:1775 83. 886. Vardeny O, Sweitzer NK, Detry MA, et al. Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail. 2009;15:368 73. 887. Arnold SV, Morrow DA, Wang K, et al. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 ran- domized trial. Circ Cardiovasc Qual Outcomes. 2008;1:107 15. 888. Morrow DA, Scirica BM, Chaitman BR, et al. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation. 2009;119:2032 9. 889. Timmis AD, Chaitman BR, Crager M. Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. Eur Heart J. 2006;27:42 8. 890. Scirica BM, Morrow DA, Hod H, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation. 2007;116:1647 52. 891. Mega JL, Hochman JS, Scirica BM, et al. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST- elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36). Circulation. 2010;121:1809 17. 892. Jerling M, Abdallah H. Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine. Clin Pharmacol Ther. 2005;78:288 97. 893. Markham A, Plosker GL, Goa KL. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs. 2000;60:955 74. 894. Nicorandil study ivestigators. Nicorandil for angina an update. Drug Ther Bull. 2003;41:86 8. 895. Treese N, Erbel R, Meyer J. Acute hemodynamic effects of nicorandil in coronary artery disease. J Cardiovasc Pharmacol. 1992;20 Suppl 3:S52 S56. 896. Doring G. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients. J Cardiovasc Pharmacol. 1992;20 Suppl 3:S74 S81. 897. Di Somma S, Liguori V, Petitto M, et al. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc Drugs Ther. 1993;7:119 23. 898. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269 75. 899. Rajaratnam R, Brieger DB, Hawkins R, et al. Attenuation of anti-is- chemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris. Am J Cardiol. 1999;83:1120 4, A9. 900. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004;64:1757 65. 901. Joannides R, Moore N, Iacob M, et al. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol. 2006;61:127 37. 902. Manz M, Reuter M, Lauck G, et al. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100:149 55. 903. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D. 2003;4:83 9. 904. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double- blind, multicentered, placebo-controlled trial. Circulation. 2003;107: 817 23. 905. Tardif JC, Ford I, Tendera M, et al. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 2005;26:2529 36. 906. Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807 16. 907. Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimeta- zidine shifts cardiac energy metabolism from fatty acid oxidation to Fihn et al Stable Ischemic Heart Disease: Full Text e455 glucose oxidation by inhibiting mitochondrial longchain ketoacyl coenzyme A thiolase. Circ Res. 2000;86:580 8. 908. Marzilli M, Klein WW. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials. Coron Artery Dis. 2003;14:171 9. 909. Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;CD003614. 910. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise- induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833 40. 911. Mannheimer C, Eliasson T, Augustinsson LE, et al. Electrical stimu- lation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation. 1998;97:1157 63. 912. Hautvast RW, DeJongste MJ, Staal MJ, et al. Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am Heart J. 1998;136:1114 20. 913. van der Sloot JA, Huikeshoven M, Tukkie R, et al. Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial. Ann Thorac Surg. 2004;78:875 81. 914. Guleserian KJ, Maniar HS, Camillo CJ, et al. Quality of life and survival after transmyocardial laser revascularization with the holmi- um: YAG laser. Ann Thorac Surg. 2003;75:1842 7. 915. Myers J, Oesterle SN, Jones J, et al. Do transmyocardial and percuta- neous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J. 2002;143:1052 7. 916. Ballegaard S, Pedersen F, Pietersen A, et al. Effects of acupuncture in moderate, stable angina pectoris: a controlled study. J Intern Med. 1990;227:25 30. 917. Ballegaard S, Jensen G, Pedersen F, et al. Acupuncture in severe, stable angina pectoris: a randomized trial. Acta Med Scand. 1986;220: 307 13. 918. Spertus JA, Jones PG, Coen M, et al. Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 1 month results from a randomized controlled trial. Am J Med. 2001; 111:341 8. 919. Bridges CR, Horvath KA, Nugent WC, et al. The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascular- ization. Ann Thorac Surg. 2004;77:1494 502. 920. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J. 1946;55:117 9. 921. Stone GW, Teirstein PS, Rubenstein R, et al. A prospective, multi- center, randomized trial of percutaneous transmyocardial laser revas- cularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39:1581 7. 922. Oesterle SN, Sanborn TA, Ali N, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000;356:1705 10. 923. Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revas- cularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170 7. 924. Frazier OH, March RJ, Horvath KA. Transmyocardial revasculariza- tion with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021 8. 925. Jones JW, Schmidt SE, Richman BW, et al. Holmium:YAG laser transmyocardial revascularization relieves angina and improves func- tional status. Ann Thorac Surg. 1999;67:1596 601. 926. Galinanes M, Loubani M, Sensky PR, et al. Efficacy of transmyo- cardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina. Ann Thorac Surg. 2004;78:122 8. 927. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet. 1999;354:885 90. 928. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyo- cardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029 36. 929. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised con- trolled trial. Lancet. 1999;353:519 24. 930. Dowling RD, Petracek MR, Selinger SL, et al. Transmyocardial revas- cularization in patients with refractory, unstable angina. Circulation. 1998;98:II73 II75. 931. Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascu- larization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg. 2004;77:1228 34. 932. Liao L, Sarria-Santamera A, Matchar DB, et al. Meta-analysis of survival and relief of angina pectoris after transmyocardial revascular- ization. Am J Cardiol. 2005;95:1243 5. 933. Mukherjee D, Bhatt DL, Roe MT, et al. Direct myocardial revascular- ization and angiogenesis how many patients might be eligible? Am J Cardiol. 1999;84:598 600, A8. 934. Bernstein SJ, Brorsson B, Aberg T, et al. Appropriateness of referral of coronary angiography patients in Sweden. SECOR/SBU Project Group. Heart. 1999;81:470 7. 935. Brorsson B, Bernstein SJ, Brook RH, et al. Quality of life of patients with chronic stable angina before and four years after coronary revas- cularisation compared with a normal population. Heart. 2002;87: 140 5. 936. Akhtar M, Wu GF, Du ZM, et al. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol. 2006;98: 28 30. 937. Shechter M, Matetzky S, Feinberg MS, et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol. 2003;42:2090 5. 938. Urano H, Ikeda H, Ueno T, et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial is- chemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93 9. 939. Shah SA, Shapiro RJ, Mehta R, et al. Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis. Pharmacotherapy. 2010;30:639 45. 940. Stys TP, Lawson WE, Hui JC, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822 4. 941. Barsness G, Feldman AM, Holmes DR Jr, et al. The International EECP Patient Registry (IEPR): design, methods, baseline character- istics, and acute results. Clin Cardiol. 2001;24:435 42. 942. Amin F, Al Hajeri A, Civelek B, et al. Enhanced external counterpul- sation for chronic angina pectoris. Cochrane Database Syst Rev. 2010; CD007219. 943. De Jongste MJ, Haaksma J, Hautvast RW, et al. Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocar- diographic study. Br Heart J. 1994;71:413 8. 944. De Landsheere C, Mannheimer C, Habets A, et al. Effect of spinal cord stimulation on regional myocardial perfusion assessed by positron emission tomography. Am J Cardiol. 1992;69:1143 9. 945. Hautvast RW, Blanksma PK, DeJongste MJ, et al. Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol. 1996;77:462 7. 946. Di Pede F, Lanza GA, Zuin G, et al. Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris. Am J Cardiol. 2003;91:951 5. 947. Lapenna E, Rapati D, Cardano P, et al. Spinal cord stimulation for patients with refractory angina and previous coronary surgery. Ann Thorac Surg. 2006;82:1704 8. 948. Richter A, Herlitz J, Hjalmarson A. Effect of acupuncture in patients with angina pectoris. Eur Heart J. 1991;12:175 8. 949. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Cir- culation. 2010;121:2645 53. 950. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961 72. 951. Feit F, Brooks MM, Sopko G, et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: com- parison with the randomized trial. BARI Investigators. Circulation. 2000;101:2795 802. 952. King SB III, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Inves- tigators. Am J Cardiol. 1997;79:1453 9. 953. Chakravarty T, Buch MH, Naik H, et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol. 2011;107: 360 6. 954. Grover FL, Shroyer AL, Hammermeister K, et al. A decade s expe- rience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases. Ann Surg. 2001;234:464 72. 955. Kim YH, Park DW, Kim WJ, et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Intv. 2010;3:612 23. 956. Shahian DM, O Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S2 22. 957. Shahian DM, O Brien SM, Normand SL, et al. Association of hospital coronary artery bypass volume with processes of care, mortality, mor- bidity, and the Society of Thoracic Surgeons composite quality score. J Thorac Cardiovasc Surg. 2010;139:273 82. 958. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascular- ization. J Am Coll Cardiol. 2008;51:538 45. 959. Dzavik V, Ghali WA, Norris C, et al. Long-term survival in 11 661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J. 2001;142:119 26. 960. Takaro T, Hultgren HN, Lipton MJ, et al. The VA cooperative ran- domized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation. 1976;54: III107 III117. 961. Takaro T, Peduzzi P, Detre KM, et al. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Coop- erative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation. 1982;66:14 22. 962. Taylor HA, Deumite NJ, Chaitman BR, et al. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation. 1989;79:1171 9. 963. Capodanno D, Caggegi A, Miano M, et al. Global Risk Classification and Clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization. J Am Coll Cardiol Intv. 2011;4:287 97. 964. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331 41. 965. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 199 1996. Circulation. 1997;96: 3867 72. 966. Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing per- cutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J. 2008;155:274 83. 967. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57:538 45. 968. Brener SJ, Galla JM, Bryant R III, et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol. 2008;101: 169 72. 969. Chieffo A, Magni V, Latib A, et al. 5-year outcomes following percu- taneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the milan experience. J Am Coll Cardiol Intv. 2010;3: 595 601. 970. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113: 2542 7. 971. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with druge- luting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006;47:864 70. 972. Makikallio TH, Niemela M, Kervinen K, et al. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Ann Med. 2008;40: 437 43. 973. Naik H, White AJ, Chakravarty T, et al. A meta-analysis of 3773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. J Am Coll Cardiol Intv. 2009;2:739 47. 974. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006;98:54 9. 975. Park DW, Seung KB, Kim YH, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN- COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2010; 56:117 24. 976. Rodes-Cabau J, Deblois J, Bertrand OF, et al. Nonrandomized com- parison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 2008;118:2374 81. 977. Sanmartin M, Baz JA, Claro R, et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol. 2007;100:970 3. 978. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781 92. 979. White A, Kedia G, Mirocha J, et al. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. J Am Coll Cardiol Card Inter. 2008;1:236 45. 980. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32:2125 34. 981. Montalescot G, Brieger D, Eagle KA, et al. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J. 2009;30:2308 17. 982. Lee MS, Tseng CH, Barker CM, et al. Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg. 2008;86:29 34. 983. Lee MS, Bokhoor P, Park SJ, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contem- porary review and argument for percutaneous coronary intervention. J Am Coll Cardiol Intv. 2010;3:791 5. 984. Park SJ, Kim YH, Park DW, et al. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2011;364:1718 27. 985. Jones RH, Kesler K, Phillips HR III, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Car- diovasc Surg. 1996;111:1013 25. 986. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332 7. 987. Smith PK, Califf RM, Tuttle RH, et al. Selection of surgical or percu- taneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006;82:1420 8. 988. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290 5. 989. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174 83. 990. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Fihn et al Stable Ischemic Heart Disease: Full Text e457 implications for the role of myocardial viability assessment in man- agement decisions. J Thorac Cardiovasc Surg. 1998;116:997 1004. 991. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation. 2005;112: I311 I316. 992. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascular- ization. Circulation. 1997;95:2037 43. 993. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts effects on survival over a 15-year period. N Engl J Med. 1996;334:216 9. 994. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal- mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1 6. 995. Cashin WL, Sanmarco ME, Nessim SA, et al. Accelerated progression of atherosclerosis in coronary vessels with minimal lesions that are bypassed. N Engl J Med. 1984;824 8. 996. Pijls NH, de BB, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703 8. 997. Tonino PA, de BB, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213 24. 998. Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascu- larized patients with left ventricular dysfunction. J Am Coll Cardiol. 2003;42:2099 105. 999. O Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year expe- rience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90:101 7. 1000. Phillips HR, O Connor CM, Rogers J. Revascularization for heart failure. Am Heart J. 2007;153:65 73. 1001. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation. 2006;113:230 7. 1002. Tsuyuki RT, Shrive FM, Galbraith PD, et al. Revascularization in patients with heart failure. CMAJ. 2006;175:361 5. 1003. Borger van der Burg AE, Bax JJ, Boersma E, et al. Impact of percu- taneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. Am J Cardiol. 2003;91:785 9. 1004. Kaiser GA, Ghahramani A, Bolooki H, et al. Role of coronary artery surgery in patients surviving unexpected cardiac arrest. Surgery. 1975; 78:749 54. 1005. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascular- ization Investigation (BARI). Circulation. 1997;96:1761 9. 1006. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: com- parison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 1007. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eightyear outcomes. J Am Coll Cardiol. 2003;41:1293 304. 1008. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082 9. 1009. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circu- lation. 2005;112:I371 I376. 1010. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or per- cutaneous coronary revascularization: results of a large regional pro- spective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 2001;37:1008 15. 1011. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multi- vessel coronary artery disease. J Am Coll Cardiol. 1998;31:10 9. 1012. Benzer W, Hofer S, Oldridge NB. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz. 2003;28:421 8. 1013. Bonaros N, Schachner T, Ohlinger A, et al. Assessment of healthrelated quality of life after coronary revascularization. Heart Surg Forum. 2005;8:E380 E385. 1014. Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321:73 7. 1015. Favarato ME, Hueb W, Boden WE, et al. Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial. Int J Cardiol. 2007;116:364 70. 1016. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949 57. 1017. Pocock SJ, Henderson RA, Seed P, et al. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation. 1996;94:135 42. 1018. Pocock SJ, Henderson RA, Clayton T, et al. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol. 2000;35:907 14. 1019. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001;358:951 7. 1020. Wijeysundera HC, Nallamothu BK, Krumholz HM, et al. Metaanaly- sis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med. 2010;152:370 9. 1021. Gurfinkel EP, Perez de la Hoz R, Brito VM, et al. Invasive vs non- invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol. 2007;119:65 72. 1022. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary inter- vention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol. 2001;38:143 9. 1023. Subramanian S, Sabik JF, Houghtaling PL, et al. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. Ann Thorac Surg. 2009;87:1392 8. 1024. Pfautsch P, Frantz E, Ellmer A, et al. [Long-term outcome of therapy of recurrent myocardial ischemia after surgical revascularization]. Z Kardiol. 1999;88:489 97. 1025. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868 77. 1026. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540 9. 1027. Stamou SC, Boyce SW, Cooke RH, et al. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol. 2002; 89:1365 8. 1028. Deleted in proof. 1029. Brener SJ, Lytle BW, Casserly IP, et al. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur Heart J. 2006;27: 413 8. 1030. Lytle BW, Loop FD, Taylor PC, et al. The effect of coronary reop- eration on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1993; 105:605 12. 1031. Sergeant P, Blackstone E, Meyns B, et al. First cardiological or car- diosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting. Eur J Cardiothorac Surg. 1998;14: 480 7. 1032. Stephan WJ, O Keefe JH Jr, Piehler JM, et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol. 1996;28:1140 6. 1033. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Re- vascularization Therapy Study (ARTS) trial. Circulation. 2001;104: 533 8. 1034. Deleted in proof. 1035. The Veterans Administration Coronary Artery Bypass Surgery Coop- erative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation. 1992;86:121 30. 1036. Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665 71. 1037. Al Suwaidi J, Holmes DR Jr, Salam AM, et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: metaanal- ysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J. 2004;147: 815 22. 1038. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med. 2003;138: 777 86. 1039. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quan- titative 20-year synopsis and a network meta-analysis. Lancet. 2009; 373:911 8. 1040. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356:1030 9. 1041. Cecil WT, Kasteridis P, Barnes JW Jr, et al. A meta-analysis update: percutaneous coronary interventions. Am J Manag Care. 2008;14: 521 8. 1042. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-anal- ysis. Circulation. 2005;111:2906 12. 1043. Schomig A, Mehilli J, de Waha A, et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52:894 904. 1044. Katritsis DG, Ioannidis JP. PCI for stable coronary disease. N Engl J Med. 2007;357:414 5. 1045. Hambrecht R, Walther C, Mobius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004; 109:1371 8. 1046. Coronary angioplasty versus coronary artery bypass surgery: the Ran- domized Intervention Treatment of Angina (RITA) trial. Lancet. 1993; 341:573 80. 1047. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants. Lancet. 1995;346:1179 84. 1048. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A mul- ticenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA. 1997; 277:715 21. 1049. Carrie D, Elbaz M, Puel J, et al. Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery dis- ease: results from the French Monocentric Study. Circulation. 1997; 96:II 6. 1050. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet. 1994;343:1449 53. 1051. Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial. Circulation. 1999;99:3255 9. 1052. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med. 1994;331: 1037 43. 1053. Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998;352:1419 25. 1054. Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743 51. 1055. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331: 1044 50. 1056. King SB III, Kosinski AS, Guyton RA, et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35:1116 21. 1057. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22:1060 7. 1058. Rodriguez A, Mele E, Peyregne E, et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol. 1996;27:1178 84. 1059. Wahrborg P. Quality of life after coronary angioplasty or bypass surgery. 1-year follow-up in the Coronary Angioplasty versus Bypass Revascularization investigation (CABRI) trial. Eur Heart J. 1999;20: 653 8. 1060. Coronary artery bypass surgery versus percutaneous coronary inter- vention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965 70. 1061. Cisowski M, Drzewiecki J, Drzewiecka-Gerber A, et al. Primary stenting versus MIDCAB: preliminary report-comparision of two methods of revascularization in single left anterior descending coronary artery stenosis. Ann Thorac Surg. 2002;74:S1334 S1339. 1062. Cisowski M, Drzewiecka-Gerber A, Ulczok R, et al. Primary direct stenting versus endoscopic atraumatic coronary artery bypass surgery in patients with proximal stenosis of the left anterior descending coronary artery a prospective, randomised study. Kardiol Pol. 2004; 61:253 61. 1063. Diegeler A, Thiele H, Falk V, et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med. 2002;347:561 6. 1064. Drenth DJ, Veeger NJ, Winter JB, et al. A prospective randomized trial comparing stenting with off-pump coronary surgery for highgrade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. J Am Coll Cardiol. 2002;40:1955 60. 1065. Drenth DJ, Veeger NJ, Middel B, et al. Comparison of late (four years) functional health status between percutaneous transluminal angioplasty intervention and off-pump left internal mammary artery bypass grafting for isolated high-grade narrowing of the proximal left anterior descending coronary artery. Am J Cardiol. 2004;94:1414 7. 1066. Eefting F, Nathoe H, van Dijk D, et al. Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty. Circulation. 2003;108:2870 6. 1067. Goy JJ, Kaufmann U, Goy-Eggenberger D, et al. A prospective ran- domized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc. 2000;75:1116 23. 1068. Kim JW, Lim DS, Sun K, et al. Stenting or MIDCAB using minister- notomy for revascularization of proximal left anterior descending artery? Int J Cardiol. 2005;99:437 41. 1069. Pohl T, Giehrl W, Reichart B, et al. Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheter Cardiovasc Interv. 2004;62:323 30. 1070. Reeves BC, Angelini GD, Bryan AJ, et al. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. Health Technol Assess. 2004;8:1 43. 1071. Rodriguez A, Bernardi V, Navia J, et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery Fihn et al Stable Ischemic Heart Disease: Full Text e459 in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol. 2001;37:51 8. 1072. Rodriguez AE, Baldi J, Fernandez Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46:582 8. 1073. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronaryartery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117 24. 1074. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46:575 81. 1075. Stroupe KT, Morrison DA, Hlatky MA, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary inter- vention for revascularization of high-risk patients. Circulation. 2006; 114:1251 7. 1076. Thiele H, Oettel S, Jacobs S, et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up. Circulation. 2005;112: 3445 50. 1077. Hong SJ, Lim DS, Seo HS, et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheter Cardiovasc Interv. 2005; 64:75 81. 1078. Thiele H, Neumann-Schniedewind P, Jacobs S, et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009; 53:2324 31. 1079. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147: 703 16. 1080. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multi- vessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190 7. 1081. Briguori C, Condorelli G, Airoldi F, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol. 2007;99:779 84. 1082. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug- eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116:I200 I206. 1083. Lee MS, Jamal F, Kedia G, et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol. 2007;123:34 42. 1084. Park DW, Yun SC, Lee SW, et al. Long-term mortality after percuta- neous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation. 2008;117:2079 86. 1085. Tarantini G, Ramondo A, Napodano M, et al. PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc Interv. 2009;73:50 8. 1086. Varani E, Balducelli M, Vecchi G, et al. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical re- vascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs. J Invasive Cardiol. 2007;19:469 75. 1087. Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2008;85: 65 70. 1088. Yang ZK, Shen WF, Zhang RY, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol. 2007;20:10 6. 1089. Benedetto U, Melina G, Angeloni E, et al. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients. Eur J Cardiothorac Surg. 2009;36: 611 5. 1090. Ragosta M, Dee S, Sarembock IJ, et al. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Car- diovasc Interv. 2006;68:357 62. 1091. Chieffo A, Park SJ, Valgimigli M, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation. 2007;116:158 62. 1092. Tamburino C, Capranzano P, Capodanno D, et al. Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation. J Am Coll Cardiol Intv. 2010;3:624 31. 1093. Ben-Gal Y, Mohr R, Braunstein R, et al. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery. Ann Thorac Surg. 2006;82:2067 71. 1094. Fraund S, Herrmann G, Witzke A, et al. Midterm follow-up after minimally invasive direct coronary artery bypass grafting versus per- cutaneous coronary intervention techniques. Ann Thorac Surg. 2005; 79:1225 31. 1095. Goy JJ, Kaufmann U, Hurni M, et al. 10-year follow-up of a pro- spective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial. J Am Coll Cardiol. 2008;52:815 7. 1096. Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ. 2007; 334:617. 1097. Jaffery Z, Kowalski M, Weaver WD, et al. A meta-analysis of ran- domized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 2007;31:691 7. 1098. Kapoor JR, Gienger AL, Ardehali R, et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. J Am Coll Cardiol Intv. 2008;1:483 91. 1099. Jones EL, Craver JM, Guyton RA, et al. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol. 1983;51:7 12. 1100. Bell MR, Bailey KR, Reeder GS, et al. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival? J Am Coll Cardiol. 1990;16:553 62. 1101. Bourassa MG, Yeh W, Holubkov R, et al. Long-term outcome of patients with incomplete vs complete revascularization after multi- vessel PTCA. A report from the NHLBI PTCA Registry. Eur Heart J. 1998;19:103 11. 1102. Faxon DP, Ghalilli K, Jacobs AK, et al. The degree of revascularization and outcome after multivessel coronary angioplasty. Am Heart J. 1992;123:854 9. 1103. Berger PB, Velianou JL, Aslanidou Vlachos H, et al. Survival fol- lowing coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2001;38:1440 9. 1104. Gioia G, Matthai W, Gillin K, et al. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheter Car- diovasc Interv. 2007;70:26 33. 1105. O Keefe JH Jr, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ven- tricular ejection fraction , or 5 40%. Am J Cardiol. 1993;71:897 901. 1106. Cole JH, Jones EL, Craver JM, et al. Outcomes of repeat revascular- ization in diabetic patients with prior coronary surgery. J Am Coll Cardiol. 2002;40:1968 75. 1107. Choudhry NK, Singh JM, Barolet A, et al. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials. Am J Med. 2005; 118:465 74. 1108. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST- elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360:743 51. 1109. Fox KA, Clayton TC, Damman P, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non- STsegment elevation acute coronary syndrome a meta-analysis of indi- vidual patient data. J Am Coll Cardiol. 2010;55:2435 45. 1110. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813 8. 1111. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998; 339:1665 71. 1112. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in ran- domized clinical trials of drug-eluting stents. N Engl J Med. 2007;356: 1020 9. 1113. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug- eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519 21. 1114. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159 68. 1115. Peterson ED, Kaul P, Kaczmarek RG, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2003;42:1611 6. 1116. Bonatti J, Schachner T, Bonaros N, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology. 2008;110:92 5. 1117. Gilard M, Bezon E, Cornily JC, et al. Same-day combined percutane- ous coronary intervention and coronary artery surgery. Cardiology. 2007;108:363 7. 1118. Holzhey DM, Jacobs S, Mochalski M, et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008;86: 1856 60. 1119. Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg. 2008;135:367 75. 1120. Reicher B, Poston RS, Mehra MR, et al. Simultaneous hybrid per- cutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008;155:661 7. 1121. Vassiliades TA Jr, Douglas JS, Morris DC, et al. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg. 2006;131:956 62. 1122. Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and stop hybrid revascularization results from a fully integrated hybrid cathe- terization laboratory/operating room. J Am Coll Cardiol. 2009;53: 232 41. 1123. Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thora- cotomy and angioplasty for multivessel coronary artery revasculari- sation. Lancet. 1996;347:757 8. 1124. Simoons ML. Myocardial revascularization bypass surgery or angio- plasty? N Engl J Med. 1996;335:275 7. 1125. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myo- cardial Infarction 2 Participants. N Engl J Med. 1999;341:217 25. 1126. Merz NB, Johnson BD, Kelsey PSF, et al. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care. 2001;7:959 65. 1127. Sharaf BL, Pepine CJ, Kerensky RA, et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women s Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001; 87:937 41. 1128. Bugiardini R, Bairey Merz CN. Angina with normal coronary arter- ies: a changing philosophy. JAMA. 2005;293:477 84. 1129. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovas- cular outcomes in women with nonobstructive coronary artery disease: a report from the Women s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169: 843 50. 1130. Sullivan AK, Holdright DR, Wright CA, et al. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308:883 6. 1131. Kwong RY, Farzaneh-Far A. Measuring myocardial scar by CMR. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:157 60. 1132. Lerakis S, Janik M, McLean DS, et al. Adenosine stress magnetic resonance imaging in women with low risk chest pain: the Emory University experience. Am J Med Sci. 2010;339:216 20. 1133. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69 77. 1134. Santana-Boado C, Candell-Riera J, Castell-Conesa J, et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med. 1998;39:751 5. 1135. Philpott S, Boynton PM, Feder G, et al. Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. Soc Sci Med. 2001;52:1565 75. 1136. Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006; 113:490 8. 1137. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832 7. 1138. Dey S, Flather MD, Devlin G, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95:20 6. 1139. Jacobs AK, Johnston JM, Haviland A, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol. 2002;39:1608 14. 1140. Holubkov R, Laskey WK, Haviland A, et al. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. Am Heart J. 2002;144:826 33. 1141. Vaccarino V, Abramson JL, Veledar E, et al. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation. 2002;105:1176 81. 1142. Edwards FH, Carey JS, Grover FL, et al. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg. 1998;66:125 31. 1143. Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology- National Cardiovascular Data Registry (ACC-NCDR) experience: 1998 2000. J Am Coll Cardiol. 2002;39:1104 12. 1144. Singh M, Rihal CS, Lennon RJ, et al. Prediction of complications following nonemergency percutaneous coronary interventions. Am J Cardiol. 2005;96:907 12. 1145. Shaw RE, Anderson HV, Brindis RG, et al. Updated risk adjustment mortality model using the complete 1.1 dataset from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR). J Invasive Cardiol. 2003;15:578 80. 1146. Moscucci M, Kline-Rogers E, Share D, et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation. 2001;104:263 8. 1147. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47:654 60. 1148. Singh M, Rihal CS, Gersh BJ, et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol. 2008;51:2313 20. 1149. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:387 93. 1150. Hannan EL, Wu C, Bennett EV, et al. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol. 2006;47:661 8. Fihn et al Stable Ischemic Heart Disease: Full Text e461 1151. Katzel LI, Sorkin JD, Goldberg AP. Exercise-induced silent myo- cardial ischemia and future cardiac events in healthy, sedentary, middle-aged and older men. J Am Geriatr Soc. 1999;47:923 9. 1152. Innocenti F, Totti A, Baroncini C, et al. Prognostic value of dobuta- mine stress echocardiography in octogenarians. Int J Cardiovasc Imaging. 2011;27:65 74. 1153. Perrone-Filardi P, Costanzo P, Dellegrottaglie S, et al. Prognostic role of myocardial single photon emission computed tomography in the elderly. J Nucl Cardiol. 2010;17:310 5. 1154. Bouzas-Mosquera A, Peteiro J, Broullon FJ, et al. Value of exercise echocardiography for predicting mortality in elderly patients. Eur J Clin Invest. 2010;40:1122 30. 1155. Bernheim AM, Kittipovanonth M, Takahashi PY, et al. Does the prognostic value of dobutamine stress echocardiography differ among different age groups? Am Heart J. 2011;161:740 5. 1156. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096 104. 1157. Karlson BW, Herlitz J, Pettersson P, et al. One-year prognosis in patients hospitalized with a history of unstable angina pectoris. Clin Cardiol. 1993;16:397 402. 1158. Kwok JM, Miller TD, Hodge DO, et al. Prognostic value of the Duke treadmill score in the elderly. J Am Coll Cardiol. 2002;39:1475 81. 1159. Avezum A, Makdisse M, Spencer F, et al. Impact of age on man- agement and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005;149:67 73. 1160. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879 87. 1161. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393 9. 1162. Maron DJ, Spertus JA, Mancini GB, et al. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revasculariza- tion and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol. 2009;104:1055 62. 1163. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the ran- domized TIME trial. JAMA. 2003;289:1117 23. 1164. Resnic FS, Ohno-Machado L, Selwyn A, et al. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol. 2001; 88:5 9. 1165. Qureshi MA, Safian RD, Grines CL, et al. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1890 5. 1166. Feldman DN, Gade CL, Slotwiner AJ, et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (,60, 60 to 80, and .80 years) (from the New York State Angioplasty Registry). Am J Cardiol. 2006;98:1334 9. 1167. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856 64. 1168. Freeman WK, Schaff HV, O Brien PC, et al. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol. 1991;18:29 35. 1169. Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly. The national Medicare experience. Ann Intern Med. 1994;121:919 27. 1170. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434 44. 1171. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med. 2000;342:1040 2. 1172. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and car- diovascular disease: an update. Hypertension. 2001;37:1053 9. 1173. Blendea MC, McFarlane SI, Isenovic ER, et al. Heart disease in diabetic patients. Curr Diab Rep. 2003;3:223 9. 1174. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229 34. 1175. Hueb W, Gersh BJ, Costa F, et al. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg. 2007;83:93 9. 1176. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percu- taneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Re- vascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55:432 40. 1177. Farkouh ME, Dangas G, Leon MB, et al. Design of the Future REvas- cularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008;155:215 23. 1178. Goel K, Thomas RJ, Squires RW, et al. Combined effect of cardiore- spiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J. 2011;161:590 7. 1179. Goyal D, Logie IM, Nadar SK, et al. Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing. Cardiovasc Ther. 2009;27:10 6. 1180. McNulty PH, Ettinger SM, Field JM, et al. Cardiac catheterization in morbidly obese patients. Catheter Cardiovasc Interv. 2002;56:174 7. 1181. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285 95. 1182. Brosius FC III, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation. 2006;114:1083 7. 1183. Matzkies FK, Reinecke H, Regetmeier A, et al. 